Moneysupermarket.com Q3 Revenue Down, Sees FY EBITDA In Line With Current Market View

Moneysupermarket.com Group Plc (MONY.L) reported Tuesday that its third-quarter total revenue declined 10 percent from last year to 76.4 million pounds.

Looking ahead, the company said it anticipates full-year EBITDA in line with current market expectations

Across the business, the company expects to see continued strong gross margin performance. The company said it does not anticipate energy market conditions will improve this year and therefore expect that switching will be negligible in the fourth quarter.

In its trading update, the company said Insurance revenue dropped 10 percent to 41.3 million pounds, and Home Services revenue fell 46 percent to 13.9 million pounds.

However, revenues from Money segment grew 58 percent and travel increased 29 percent.

Peter Duffy, CEO of Moneysupermarket, said, "We have continued to make improvements in our business, building towards a leading data, marketing and technology platform. We maintained our strong margin performance and good cash conversion despite the very tough energy market. We are encouraged by the performance of Money and the early signs of Travel recovery following changes to travel restrictions."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Privately-held biotechnology company On Target Laboratories, Inc. announce that the U.S. Food and Drug Administration or FDA, has approved Cytalux (pafolacianine) for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions. Cytalux is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively. The Federal Trade Commission or FTC has ordered Walmart, Amazon, Kroger and certain other large wholesalers and suppliers to provide information to help it study causes of supply chain disruptions. The agency has launched an inquiry to find the reasons for empty shelves and exorbitant prices. Along with Walmart, Amazon.com, and Kroger, the order has been sent to C&S Wholesale Grocers, Associated.. Covid vaccine maker Moderna Inc.'s Chief Executive Stéphane Bancel has predicted that existing COVID-19 vaccines will be much less effective against Omicron than earlier strains, according to the Financial Times.
Follow RTT